Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA moves toward easing restrictions on certain peptides BioPharma Dive The Emerging Risk of Peptides in Supplements LegitScript The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York